Abstract:Excitotoxicity linked either to environmental causes (pesticide and cyanotoxin exposure), excitatory neurotransmitter imbalance, or to intrinsic neuronal hyperexcitability, is a pathological mechanism central to neurodegeneration in amyotrophic lateral sclerosis (ALS). Investigation of excitotoxic mechanisms using in vitro and in vivo animal models has been central to understanding ALS mechanisms of disease. In particular, advances in induced pluripotent stem cell (iPSC) technologies now provide human cell-based models that are readily amenable to environmental and network-based excitotoxic manipulations. The cell-type specific differentiation of iPSC, combined with approaches to modelling excitotoxicity that include editing of disease-associated gene variants, chemogenetics, and environmental risk-associated exposures make iPSC primed to examine gene-environment interactions and disease-associated excitotoxic mechanisms. Critical to this is knowledge of which neurotransmitter receptor subunits are expressed by iPSC-derived neuronal cultures being studied, how their activity responds to antagonists and agonists of these receptors, and how to interpret data derived from multi-parameter electrophysiological recordings. This review explores how iPSC-based studies have contributed to our understanding of ALS-linked excitotoxicity and highlights novel approaches to inducing excitotoxicity in iPSC-derived neurons to further our understanding of its pathological pathways.

Invertebrate genetic models of amyotrophic lateral sclerosis

In Vitro Models of Amyotrophic Lateral Sclerosis

The usage and advantages of several common amyotrophic lateral sclerosis animal models

Pathological insights from amyotrophic lateral sclerosis animal models: comparisons, limitations, and challenges

From Mouse Models to Human Disease: An Approach for Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis Mechanism: Insights from the Caenorhabditis elegans Models

Promising animal models for amyotrophic lateral sclerosis drug discovery: a comprehensive update

Murine experimental models of amyotrophic lateral sclerosis: an update

Mouse models of ALS: Past, present and future

CRISPR/Cas9: implication for modeling and therapy of amyotrophic lateral sclerosis

New developments in pre-clinical models of ALS to guide translation

Modeling cell-autonomous motor neuron phenotypes in ALS using iPSCs

Simple models to understand complex disease: 10 years of progress from Caenorhabditis elegans models of amyotrophic lateral sclerosis and frontotemporal lobar degeneration

Genetically modified large animal models for investigating neurodegenerative diseases

Amyotrophic Lateral Sclerosis Genetic Studies

A comprehensive review of electrophysiological techniques in amyotrophic lateral sclerosis research

Recent progress of the genetics of amyotrophic lateral sclerosis and challenges of gene therapy

ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?

How is Excitotoxicity Being Modelled in iPSC-Derived Neurons?

Progress in the Study of ALS Causative Genes

Dysfunction of Autophagy As the Pathological Mechanism of Motor Neuron Disease Based on a Patient-Specific Disease Model